| Literature DB >> 30539114 |
Leandro Tolfo Franzoni1, Elren Passos Monteiro1, Henrique Bianchi Oliveira1, Rodrigo Gomes da Rosa1, Rochelle Rocha Costa1, Carlos Rieder2, Flávia Gomes Martinez1, Leonardo Alexandre Peyré-Tartaruga1.
Abstract
Aerobic training has a neuroprotective effect in people with Parkinson's disease. Recent evidence indicates that Nordic walking seems a promising alternative due to positive outcomes in functional mobility. However, the effects of Nordic walking compared to free walking on static and functional balance parameters are still unknown. The aim of this study was to evaluate the effects of nine weeks of Nordic and free walking training on static and functional balance. The sample size was 33 individuals with eight dropouts, leaving 25 individuals in the final sample (Nordic Walking, n=14, Free Walking, n=11). The participants underwent two evaluations in the present randomized clinical trial, pre- and post-training, to determine average velocity and root-mean-square values from center of pressure with eyes open and eyes closed. The functional balance showed approximately 5% improvement for the two groups ( p =0.04). The results indicate that nine weeks of Nordic and free walking training were enough to induce improvements in the proprioceptive system and functional balance.Entities:
Keywords: Berg balance scale; aerobic training; locomotion; postural balance; walking sticks
Year: 2018 PMID: 30539114 PMCID: PMC6225959 DOI: 10.1055/s-0043-124757
Source DB: PubMed Journal: Sports Med Int Open ISSN: 2367-1890
Fig. 1Flowchart of selection process and inclusion of volunteers. PD=Parkinson’s disease; DBS=deep brain stimulation; RCT=randomized clinical trial.
Table 1 Characterization of participants with mean values (95% confidence interval) for NW and FW groups.
| Variable | NW=14 | FW=11 |
|
|---|---|---|---|
|
| 1.68 (1.64 to 1.72) | 1.59 (1.55 to 1.63) | 0.003 |
|
| 81.71 (73.28 to 90.14) | 64.75 (57.13 to 72.37) | 0.004 |
|
| 64.43 (58.57 to 70.28) | 71.09 (66.88 to 75.30) | 0.069 |
|
| 15.78 (7.62 to 23.94) | 23.18 (11.03 to 35.33) | 0.262 |
|
| 1.60 (1.22 to 1.98) | 2.04 (1.30 to 2.78) | 0.229 |
NW=Nordic walking; FW=free walking; UPDRS=Unified Parkinson’s Disease Rating Scale.
Table 2 Mean (95% confidence interval) values from center of pressure parameters.
| Variable | Group | Eyes closed | Eyes open | ||
|---|---|---|---|---|---|
| T1 | T2 | T1 | T2 | ||
| Mean±SE | Mean±SE | Mean±SE | Mean±SE | ||
| AV (mm.s -1 ) | FW | 27.12 (20.25 to 33.99) | 39.48 (27.13 to 51.83) | 19.56 (15.18 to 23.93) | 35.41 (26.51 to 44.32) |
| NW | 38.48 (25.47 to 51.49) | 48.29 (31.56 to 65.01) | 26.64 (16.65 to 32.63) | 31.78 (20.67 to 42.90) | |
| RMS AP (mm) | FW | 7.15 (5.82 to 8.47) a,A | 11.75 (8.56 to 14.93) a,B | 6.54 (4.80 to 8.27) a,A | 10.47 (7.79 to 13.14) a,B |
| NW | 8.31 (6.49 to 10.12) a,A | 14.94 (11.78 to 18.09) a,B | 7.34 (5.32 to 9.34) a,A | 13.25 (10.97 to 15.53) a,B | |
| RMS ML (mm) | FW | 6.50 (4.34 to 8.65) a,A | 10.79 (8.07 to 13.51) a,B | 5.52 (4.21 to 6.83) a,A | 9.91 (7.19 to 12.62) a,B |
| NW | 7.47 (6.27 to 8.67) a,A | 10.74 (7.58 to 13.89) a,B | 6.15 (4.88 to 7.42) a,A | 8.35 (6.13 to 10.57) a,B | |
| ADA AP (mm) | FW | 38.24 (30.11 to 46.38) a,A | 57.93 (41.48 to 74.38) a,B | 32.46 (24.61 to 40.31) a,A | 56.12 (38.93 to 73.31) a,B |
| NW | 41.81 (33.75 to 49.86) a,A | 73.57 (55.90 to 91.24) a,B | 34.55 (26.62 to 42.48) a,A | 63.03 (53.31 to 72.75) a,B | |
| ADA ML (mm) | FW | 32.53 (24.16 to 40.90) a,A | 47.47 (35.20 to 59.75) a,B | 25.52 (20.62 to 30.41) a,A | 47.46 (36.27 to 58.66) a,B |
| NW | 37.69 (30.91 to 44.46) a,A | 48.65 (30.89 to 66.40) a,B | 34.25 (23.35 to 45.15) a,A | 41.77 (30.74 to 52.80) a,B | |
Note: Non-capitalized letter indicates differences from Bonferroni test (p<0.05) between groups (FW vs. NW). Capitalized letter indicates differences from Bonferroni test (p<0.05) between times (T1 vs. T2). T1=pre-test; T2=post-test; AV=average velocity; RMS=root mean square; AP=anteroposterior; ML=mediolateral; ADA=average displacement amplitude; FW=free walking; NW=Nordic walking.
Table 3 Main effects for Group (NW vs. FW), Time (T1 vs. T2), and Condition (eyes open vs. eyes closed), and interaction effects for the parameters from center of pressure.
| Variable | Group | Time | Condition | Group* Time | Group* Condition | Time* Condition | Group*Time*Condition |
|---|---|---|---|---|---|---|---|
| AV (mm.s -1 ) | 0.368 | 0.011 | <0.001 | 0.527 | 0.013 | 0.864 | 0.204 |
| AP RMS (mm) | 0.155 | <0.001 | 0.043 | 0.157 | 0.733 | 0.352 | 0.980 |
| ML RMS (mm) | 0.999 | <0.001 | 0.002 | 0.231 | 0.295 | 0.582 | 0.514 |
| AP ADA (mm) | 0.323 | <0.001 | 0.026 | 0.292 | 0.371 | 0.937 | 0.409 |
| ML ADA (mm) | 0.690 | <0.001 | 0.076 | 0.257 | 0.737 | 0.722 | 0.297 |
AV=average velocity; RMS=root mean square; AP=anteroposterior; ML=mediolateral; ADA=average displacement amplitude; FW=free walking; NW=Nordic walking; T1=pre-test; T2=post-test.
Table 4 Mean values (95% confidence interval) of functional balance for both groups.
| T1 | T2 | P=value | ||||
|---|---|---|---|---|---|---|
| Group | Time | Group*Time | ||||
| BBS | NW FW | 51.50 (48.99 to 54.01) 47.09 (40.17 to 54.02) | 53.79 (52.12 to 55.46) 50.91 (47.59 to 54.23) | 0.15 | 0.04* | 0.61 |
Note: * indicates statistically significant difference. Initial evaluation, baseline (T1); evaluation after training (T2).